Hydrochloric Acid

Hydrochloric Acid

SCHEMBL7922492

Cl.O=C(CCN1CCOCC1)c1cc(Cl)ccc1Cl

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
MAPT P10636 5/20 0.64
KMT2A Q03164 4/20 0.64
KDM4E B2RXH2 1/20 0.58
THRB P10828 6/20 0.53
LMNA P02545 2/20 0.52
MPI P34949 1/20 0.52
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12123824 0.85 ALDH1A1 (0.56) ALDH1A1MAPTKMT2ATHRBLMNA
SCHEMBL12123783 0.82 ALDH1A1 (0.64) ALDH1A1MAPTKMT2ATHRBLMNA
Hydrochloric Acid SCHEMBL7932172 0.80 ALDH1A1 (0.70) ALDH1A1MAPTKMT2ATHRBLMNA
SCHEMBL7255774 0.79 ALDH1A1 (1.00) ALDH1A1MAPTKMT2ATHRBLMNA
Hydrochloric Acid SCHEMBL7929072 0.78 ALDH1A1 (0.70) ALDH1A1MAPTKMT2AKDM4ETHRB
SCHEMBL12123774 0.78 ALDH1A1 (0.72) ALDH1A1MAPTKMT2ALMNAMPI
SCHEMBL12123785 0.77 ALDH1A1 (0.70) ALDH1A1MAPTKMT2AKDM4ELMNA
SCHEMBL11493992 0.75 ALDH1A1 (0.91) ALDH1A1MAPTKMT2ATHRBLMNA
SCHEMBL12123799 0.74 ALDH1A1 (0.62) ALDH1A1MAPTKMT2ATHRBLMNA
SCHEMBL5092511 0.74 ALDH1A1 (0.56) ALDH1A1MAPTKMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3009473-B2 2000-02-14 JP claimed
US-5705501-A ADMINISTERING TO INHIBIT FORMATION OF ABNORMAL PHOSPHORYLATED PAIRED HELICAL FILAMENT EPITOPES MOLECULAR GERIATRICS CORPORATION (US) 1998-01-06 US claimed
EP-0792151-A2 USE OF SUBSTITUTED ARYL-MORPHOLINO-, THIOMORPHOLINO- OR PIPERAZINO-PROPANONES FOR THE TREATEMENT OF PREVENTION OF ALZHEIMER'DISEASE MOLECULAR GERIATRICS CORPORATION (US) 1997-09-03 EP claimed
WO-1996015791-A2 USE OF SUBSTITUTED ARYL-MORPHOLINO-, THIOMORPHOLINO- OR PIPERAZINO-PROPANONES FOR THE TREATEMENT OF PREVENTION OF ALZHEIMER'DISEASE MOLECULAR GERIATRICS CORPORATION (US) 1996-05-30 WO claimed
US-6228878-B1 ADMINISTERING INDOLIN-5-ONE DERIVATIVES; INHIBITING FORMATION OF ABNORMALLY PHOSPHORYLATED PAIRED HELICAL FILAMENT EPITOPES MOLECULAR GERIATRICS CORPORATION 2001-05-08 US disclosed
US-5968936-A ADMINISTERING SUBSTITUTED 4,5,6,7-TETRAHYDRO-5-MORPHOLINOMETHYL-4-OXOINDOLES MOLECUALR GERIATRICS CORPORATION (US) 1999-10-19 US disclosed
US-5705501-A ADMINISTERING TO INHIBIT FORMATION OF ABNORMAL PHOSPHORYLATED PAIRED HELICAL FILAMENT EPITOPES MOLECULAR GERIATRICS CORPORATION (US) 1998-01-06 US disclosed